Company: HCTI
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112544
Chunk: 40

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 40
---
94588. Our telephone number is (925) 270-4812.Our website address is https://www.healthcaretriangle.com/ .. The information included on our website or in any social media associated with the Company is not part of this prospectus.

<div align='center'>8</div>

Implications of Being an Emerging Growth Company We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012 (the “ JOBS Act”). We will remain an emerging growth company until the earlier of (i) the last day of the fiscal year following the fifth anniversary of the date of the first sale of our common stock pursuant to an effective registration statement under the Securities Act; (ii) the last day of the fiscal year in which we have total annual gross revenues of $1.235 billion or more; (iii) the date on which we have issued more than $1 billion in nonconvertible debt during the previous three years; or (iv) the date on which we are deemed to be a large accelerated filer under applicable SEC rules. We expect that we will remain an emerging growth company for the foreseeable future, but cannot retain our emerging growth company status indefinitely and will no longer qualify as an emerging growth company on or before the last day of the fiscal year following the fifth anniversary of the date of the first sale of our common stock pursuant to an effective registration statement under the Securities Act. For so long as we remain an emerging growth company, we are permitted and intend to rely on exemptions from specified disclosure requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include:

| ● | being permitted to provide only two years of audited financial                                                             
 statements, in addition to any required unaudited interim financial statements, with correspondingly reduced “Management’s 
 Discussion and Analysis of Financial Condition and Results of Operations” disclosure;                                      |

| ● | not being required to comply with the requirement of auditor   
 attestation of our internal controls over financial reporting; |

| ● | not being required to comply with any requirement that may                                                                           
 be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s 
 report providing additional information about the audit and the financial statements;                                                |

| ● | reduced disclosure obligations regarding executive compensation; 
 and                                                              |

| ● | not being required to hold a nonbinding advisory vote on                                                  
 executive compensation and shareholder approval of any golden parachute payments not previously approved. |

We have taken advantage